Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway

Jim Zheng(Gilead Sciences (United States)), Raju Subramanian(Gilead Sciences (United States)), Bill J. Smith(Gilead Sciences (United States)), Nathan Kozon(MACOM (United States)), Jung-Joo Yoon(Wonkwang University), Gavin Carr(MACOM (United States)), Mark Gohdes(MACOM (United States)), Michael Graupe(MACOM (United States)), William Rowe(Gilead Sciences (United States)), Bing Lu(Southern Medical University), John O. Link(Gilead Sciences (United States)), Jia Hao(MACOM (United States)), Winston C. Tse(Gilead Sciences (United States)), Mohammad Bashir(MACOM (United States)), Scott D. Schroeder(Gilead Sciences (United States)), Bernard P. Murray(Gilead Sciences (United States)), Anna Chiu(Gilead Sciences (United States)), Judy Mwangi(Gilead Sciences (United States)), Kelly McLennan Staiger(MACOM (United States)), Kelly Wang(Gilead Sciences (United States))
Journal of Pharmacology and Experimental Therapeutics
August 8, 2024
Cited by 13


Related Papers